ee
£ iC DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
% a
we
Food and Drug Administration
9200 Corporate Boulevard
Rockville MD 20850
MAR 1 4 2005
Steve Griffin, Ph.D.
Vice President Technology
InnovaQuartz, Inc.
23030 North 15" Avenue
Phoenix, Arizona 85027
Re: K050108
Trade/Device Name: SureFlex™ and AccuFlex™ Laser Lithotripsy Fibers
Regulation Number: 21 CFR 878.4810
Regulation Name: Laser surgical instrument for use in general and
plastic surgery and in dermatology
Regulatory Class: I
Product Code: GEX
Dated: December 30, 2004
Received: January 18, 2005
Dear Dr. Griffin:
We have reviewed your Section 510(k) premarket notification of intent to market the device
referenced above and have determined the device is substantially equivalent (for the indications
for use stated in the enclosure) to legally marketed predicate devices marketed in interstate
commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to
devices that have been reclassified in accordance with the provisions of the Federal Food, Drug.
and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA).
You may, therefore, market the device, subject to the general controls provisions of the Act. The
general controls provisions of the Act include requirements for annual registration, listing of
devices, good manufacturing practice, labeling, and prohibitions against misbranding and
adulteration.
If your device is classified (see above) into either class I] (Special Controls) or class II] (PMA). 1
may be subject to such additional controls. Existing major regulations affecting your device can
be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may
publish further announcements concerning your device in the Federal Register.
Please be advised that FDA’s issuance of a substantial equivalence determination does not mean
that FDA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulations administered by other Federal agencies. You must
comply with all the Act’s requirements, including, but not limited to: registration and listing (21
CER Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as sct
forth in the quality systems (QS) regulation (21 CFR Part 820). and if applicable, the electronic
product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Page 2 - Steve Griffin, Ph.D.
‘This letter will allow you to begin marketing your device as described in your Section 510K}
premarket notification. he FDA finding of substantial equivalence of your device to a legally
marketed predicate device results in a classification for your device and thus, permits your device
to proceed to the market.
[f you desire specific advice for your device on our labeling regulation (21 CFR Part 801). please
contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entived.
"Misbranding by reference to premarket notification” (21CFR Part 807.97). You may obtain
other general information on your responsibilities under the Act from the Division of Small
Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or
(301) 443-6597 or at its Internet address http://www. fda.pov/cdrh/industry/support/index.htm.
Sincerely yours, ,
ffi!
A Mean —
) Ayla Wen
i
i Miriam C. Provost, Ph.D
U Acting Director
Division of General, Restorative
and Neurological Devices
Office of Device Evaluation
Center for Devices and Radiological Health
Enclosure

Indications for Use
510(k) Number (if known): K050108
Device Name: SureFlex And AccuFlex Laser Lithotripsy Fiber
Indications for Use:
General
SureFlex™ and AccuFlex™ are intended for use in laser-based surgical applications,
including but not limited to endoscopic, laparoscopic and open surgical procedures
involving vaporization, ablation and fragmentation of calculi (urinary and biliary) and
surgical procedures involving vaporization, abaltion, coagulation, hemostasis, excision,
resection and incision of soft and cartilaginous tissue.
While designed primarily for holmium (Ho:YAG) lasers, SureFlex™ and AccuFlex™
fibers may be used with any laser wavelength between 500nm and 2200nm that have
been cleared for surgical use including, but not limited to frequency doubled Nd:YAG
(KTP) lasers, argon lasers, diode lasers, alexandrite lasers, ruby lasers, dye lasers,
Nd:YAG lasers and Tm:YAG lasers.
Specific, by Surgical Specialty (most common use first), Next Page
Prescription Use Over-The-Counter Use
(Part 21 CFR 801 ose py ANDIOR (21 CER 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE
OF NEEDED)
Concurrence of CDRH, Office if. Evaluation (ODE)
Al aa
fA a
all Ll ee
0 = oe OE

(Division Sige-OfM

Division of General, Restorative,

and Neurological Devices Page 1 of 2

Kosold
C050!
510(k) Number. 2

